Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)

NCT05067478 · clinicaltrials.gov ↗

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Vibegron

Sponsor

Urovant Sciences GmbH